This week’s breaking news was about Johnson & Johnson and Merck working together to produce Johnson & Johnsons’ COVID vaccine. CNBC pointed out that this sounded like a truly extraordinary collaboration.
But then, extraordinary times do require extraordinary efforts.
Think about it: Who would ever think that in a million years Johnson & Johnson and Merck would be in the same room and would talk to each other, let alone actually collaborate with one another on something?
But just like the CNBC anchor said, extraordinary times DO require extraordinary efforts. And they make us look at things differently.
Maybe the idea here for you is not just that there will soon be expanded vaccine inventory for you and your loved ones, but that you should look for the ways you can collaborate with unlikely partners to both redirect your efforts and thrive in these extraordinary times.
Johnson & Johnson has the patent.
Merck has the production and distribution.
Together they can get more vaccine into the arms of all of us. Faster, less expensively, AND more efficiently.
Makes a lot of sense, doesn’t it?
All YOU need to do is figure out both what you offer and what you’re missing. Then look to other practitioners to find the ones who can be the peanut butter to your jelly, the yin to your yang, and can provide the part of the equation you don’t have.
When you do this, remember not to just look at the same old usual suspects but to expand your reach to include professionals and companies you might not have thought of before… including your competition.
After all, these ARE extraordinary times. And extraordinary times call for extraordinary measures.
If you’re looking for more ways to extract extraordinary results from these extraordinary times, please consider participating in my next Core Clarity program. Seats are filling up fast and when they’re filled registration will close.
If you’d like to discover what’s in it for you, please click HERE.